Logo image of NXP

NUVEEN SELECT TAX-FREE INC (NXP) Stock Price, Quote, News and Overview

NYSE:NXP - New York Stock Exchange, Inc. - US67062F1003 - Currency: USD

14.66  -0.03 (-0.2%)

Fundamental Rating

3

NXP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NXP has a bad profitability rating. Also its financial health evaluation is rather negative. NXP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NXP was profitable.
In multiple years NXP reported negative net income over the last 5 years.
NXP had a negative operating cash flow in each of the past 5 years.
NXP Yearly Net Income VS EBIT VS OCF VS FCFNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

1.2 Ratios

The last Return On Invested Capital (3.36%) for NXP is above the 3 year average (2.39%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.68%
ROE 3.76%
ROIC 3.36%
ROA(3y)0.18%
ROA(5y)2.33%
ROE(3y)0.18%
ROE(5y)2.34%
ROIC(3y)2.39%
ROIC(5y)2.59%
NXP Yearly ROA, ROE, ROICNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 -2 4 -4 6 -6

1.3 Margins

NXP's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of NXP has remained more or less at the same level.
Industry RankSector Rank
OM 94.74%
PM (TTM) 83.36%
GM 95.29%
OM growth 3Y0.14%
OM growth 5Y0.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
NXP Yearly Profit, Operating, Gross MarginsNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

NXP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXP has more shares outstanding
NXP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXP Yearly Shares OutstandingNXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NXP Yearly Total Debt VS Total AssetsNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

NXP has an Altman-Z score of 30.11. This indicates that NXP is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that NXP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 30.11
ROIC/WACCN/A
WACCN/A
NXP Yearly LT Debt VS Equity VS FCFNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

NXP has a Current Ratio of 1.07. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
NXP has a Quick Ratio of 1.07. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
NXP Yearly Current Assets VS Current LiabilitesNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.45% over the past year.
Looking at the last year, NXP shows a very strong growth in Revenue. The Revenue has grown by 38.93%.
NXP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.68% yearly.
EPS 1Y (TTM)125.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.82%
Revenue 1Y (TTM)38.93%
Revenue growth 3Y35.45%
Revenue growth 5Y20.68%
Sales Q2Q%35.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXP Yearly Revenue VS EstimatesNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
NXP Yearly EPS VS EstimatesNXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NXP is valuated quite expensively with a Price/Earnings ratio of 27.66.
When comparing the Price/Earnings ratio of NXP to the average of the S&P500 Index (30.42), we can say NXP is valued inline with the index average.
Industry RankSector Rank
PE 27.66
Fwd PE N/A
NXP Price Earnings VS Forward Price EarningsNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXP Per share dataNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NXP has a Yearly Dividend Yield of 3.81%.
NXP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

NXP has paid a dividend for at least 10 years, which is a reliable track record.
As NXP did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years7
NXP Yearly Dividends per shareNXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NXP Yearly Income VS Free CF VS DividendNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

More info and screens

NUVEEN SELECT TAX-FREE INC

NYSE:NXP (2/20/2025, 3:31:11 PM)

14.66

-0.03 (-0.2%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-02 2024-12-02
Earnings (Next)N/A N/A
Inst Owners16.15%
Inst Owner Change6.65%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap720.98M
Analysts45
Price TargetN/A
Short Float %0.12%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years7
Ex-Date02-14 2025-02-14 (0.052)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 27.66
Fwd PE N/A
P/S 24.56
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)0.53
EY3.62%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.6
BVpS13.23
TBVpS13.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.68%
ROE 3.76%
ROCE 4.25%
ROIC 3.36%
ROICexc 3.36%
ROICexgc 3.36%
OM 94.74%
PM (TTM) 83.36%
GM 95.29%
FCFM N/A
ROA(3y)0.18%
ROA(5y)2.33%
ROE(3y)0.18%
ROE(5y)2.34%
ROIC(3y)2.39%
ROIC(5y)2.59%
ROICexc(3y)2.39%
ROICexc(5y)2.6%
ROICexgc(3y)2.4%
ROICexgc(5y)2.6%
ROCE(3y)3.02%
ROCE(5y)3.28%
ROICexcg growth 3Y-1.48%
ROICexcg growth 5Y-1.18%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-1.18%
OM growth 3Y0.14%
OM growth 5Y0.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.04%
GM growth 5Y0.02%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 30.11
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)38.93%
Revenue growth 3Y35.45%
Revenue growth 5Y20.68%
Sales Q2Q%35.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.91%
EBIT growth 3Y35.64%
EBIT growth 5Y20.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A